Grimes & Company’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Sell
5,207
-18
-0.3% -$805 ﹤0.01% 419
2026
Q1
$211K Buy
5,225
+30
+0.6% +$1.33K 0.01% 407
2025
Q4
$238K Sell
5,195
-37
-0.7% -$1.69K 0.01% 413
2025
Q3
$239K Buy
5,232
+57
+1% +$2.53K 0.01% 407
2025
Q2
$213K Buy
+5,175
New +$192K 0.01% 396
2025
Q1
Sell
-11,555
Closed -$443K 374
2024
Q4
$443K Buy
11,555
+2
+0% +$75 0.01% 264
2024
Q3
$409K Buy
+11,553
New +$365K 0.01% 253

Other funds holding BN

Grimes & Company's BN Position: Q2 2026 in Review

Grimes & Company reduced its Brookfield (BN) stake by 0.34% in Q2 2026, selling an estimated $805 and leaving 5,207 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Grimes & Company first reported a position in BN in Q3 2024 and has held it in 7 quarters since. The position peaked at $443K in Q4 2024. 355 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Grimes & Company held 5,207 shares of Brookfield worth $222K as of Q2 2026.
  • Grimes & Company sold 18 Brookfield shares in Q2 2026, an estimated $805.
  • Brookfield made up ﹤0.01% of Grimes & Company's portfolio in Q2 2026, its #419 holding.
  • Grimes & Company first reported a position in Brookfield in Q3 2024 and has held it in 7 quarters since.
  • Grimes & Company's Brookfield position peaked at $443K in Q4 2024.
  • 355 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.